Synapse - Andrew Zelenetz

Search Within

Andrew D Zelenetz

Results (785)

Tositumomab and iodine I 131 tositumomab (the BEXXAR (R) therapeutic regimen) shows efficacy in elderly patients (pts) with relapsed/refractory low-grade (LG), follicular, and transformed non-Hodgkin's lymphoma (NHL)

Meeting Abstract

Gregory, S. A.; Zelenetz, A.; Knox, S. J.; Vose, J.; Leonard, J. P.; Kaminski, M.
Blood (2004)

Fulltext@MSK | Save

The iodine I-131 tositumomab therapeutic regimen: Summary of safety in 995 patients with relapsed/refractory low grade (LG) and transformed LG non-Hodgkin's lymphoma (NHL)

Meeting Abstract

Gregory, S. A.; Leonard, J. P.; Knox, S. J.; Zelenetz, A. D.; Armitage, J.; Kaminiski, M.
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save

Evolution of Rituximab as "standard" therapy in patients (pts) with newly diagnosed follicular (FL), mantle cell (MCL), and diffuse large B cell (DLCL) non-Hodgkin's lymphoma (NHL) in 5 United States comprehensive cancer centers: An analysis from the national comprehensive cancer network (NCCN) NHL outcomes project

Meeting Abstract

Friedberg, J. W.; Kho, M. E.; Lepisto, E. M.; Rodriguez, M. A.; TerVeer, A.; LaCasce, A. S.; Nademanee, A. P.; Millenson, M.; Czuczman, M.; Niland, J.; more...
Blood (2004)

Fulltext@MSK | Save

Clinical outcome correlations of genomic gains and losses in diffuse large B-cell lymphoma by array-CGH

Meeting Abstract

Chen, W. Y.; Olshen, A.; Chaganti, S.; Halaas, J.; Zelenetz, A. D.; Feldstein, J.; Houldsworth, J.; Chaganti, R. S. K.
Blood (2004)

Fulltext@MSK | Save

The effectiveness of tositumomab and iodine I 131 tositumomab in relapsed/refractory follicular grade 1/2 and small lymphocytic non-Hodgkin's lymphoma (NHL)

Meeting Abstract

Armitage, J. O.; Leonard, J. P.; Gregory, S. A.; Horning, S. J.; Zelenetz, A. D.; Kaminski, M. S.; Fisher, R. I.
Journal of Clinical Oncology (2004)

Fulltext@MSK | Save

Effectiveness of high dose chemoradiotherapy and autologous stem cell transplantation for patients with biopsy-proven primary refractory Hodgkin's disease

Journal Article

Moskowitz, C. H.; Kewalramani, T.; Nimer, S. D.; Gonzalez, M.; Zelenetz, A. D.; Yahalom, J.
British Journal of Haematology (2004)

Fulltext@MSK | Save

Relationship between REL amplification, REL function, and clinical and biologic features in diffuse large B-cell lymphomas

Journal Article

Houldsworth, J.; Olshen, A. B.; Cattoretti, G.; Donnelly, G. B.; Teruya-Feldstein, J.; Qin, J.; Palanisamy, N.; Shen, Y.; Dyomina, K.; Petlakh, M.; more...
Blood (2004)

Fulltext@MSK | Save

Adverse prognostic significance of CD20 positive Reed-Sternberg cells in classical Hodgkin's disease

Journal Article

Portlock, C. S.; Donnelly, G. B.; Qin, J.; Straus, D.; Yahalom, J.; Zelenetz, A.; Noy, A.; O'connor, O.; Horwitz, S.; Moskowitz, C.; more...
British Journal of Haematology (2004)

Fulltext@MSK | Save

Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma

Journal Article

Kewalramani, T.; Zelenetz, A. D.; Nimer, S. D.; Portlock, C.; Straus, D.; Noy, A.; O'connor, O.; Filippa, D. A.; Teruya-Feldstein, J.; Gencarelli, A.; more...
Blood (2004)

Fulltext@MSK | Save

Non-Hodgkin's lymphoma: Clinical practice guidelines

Journal Article

Zelenetz, A. D.; Appelbaum, F. R.; Buadi, F.; Cabanillas, F.; Caligiuri, M. A.; Czuczman, M. S.; Damon, L. E.; Finn, I. E.; Forero, A.; Glenn, M. J.; more...
Journal of the National Comprehensive Cancer Network (2004)

Fulltext@MSK | Save